We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BDX icon
151
Becton Dickinson
BDX
$50.1B
$3.43M 0.06%
13,271
+1,136
+9% +$307K
2022 Q4
3 quarters
IDYA icon
152
IDEAYA Biosciences
IDYA
$3.48B
$3.4M 0.06%
126,149
-15,000
-11% -$380K
2022 Q3
4 quarters
AZN icon
153
AstraZeneca
AZN
$247B
$3.35M 0.06%
24,771
+8,000
+48% +$1.09M
2022 Q1
6 quarters
TTEK icon
154
Tetra Tech
TTEK
$8.54B
$3.34M 0.06%
109,975
+31,000
+39% +$1.01M
2023 Q2
1 quarter
GRAB icon
155
Grab
GRAB
$13.1B
$3.13M 0.06%
+885,000
New +$3.16M
2023 Q3
0 quarters
ROKU icon
156
Roku
ROKU
$22.7B
$3.1M 0.06%
43,972
+8,972
+26% +$695K
2023 Q1
2 quarters
USAR icon
157
USA Rare Earth Inc
USAR
$4.71B
$3.06M 0.05%
+300,000
New +$3.05M
2023 Q3
0 quarters
PDD icon
158
Pinduoduo
PDD
$116B
$3.04M 0.05%
30,964
-23,675
-43% -$2.04M
2022 Q3
4 quarters
EA icon
159
DELISTED
Electronic Arts
EA
$3.01M 0.05%
+25,000
New +$3.15M
2023 Q3
0 quarters
APCA icon
160
DELISTED
AP Acquisition Corp
APCA
$2.99M 0.05%
271,895
– –
2022 Q1
6 quarters
APXI icon
161
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$2.98M 0.05%
271,895
– –
2022 Q1
6 quarters
CRWD icon
162
CrowdStrike
CRWD
$282B
$2.93M 0.05%
+70,000
New +$2.72M
2023 Q3
0 quarters
BZAI icon
163
Blaize Holdings
BZAI
$42.6M
$2.87M 0.05%
271,895
– –
2022 Q1
6 quarters
SLAM icon
164
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.86M 0.05%
264,972
– –
2021 Q2
9 quarters
AXNX icon
165
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.84M 0.05%
50,676
-3,000
-6% -$169K
2022 Q1
6 quarters
NET icon
166
Cloudflare
NET
$129B
$2.84M 0.05%
+45,000
New +$2.88M
2023 Q3
0 quarters
UTHR icon
167
United Therapeutics
UTHR
$23.6B
$2.83M 0.05%
12,525
-2,000
-14% -$461K
2022 Q1
6 quarters
MRTX
168
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.82M 0.05%
64,698
+5,000
+8% +$179K
2022 Q4
3 quarters
IONS icon
169
Ionis Pharmaceuticals
IONS
$7.52B
$2.81M 0.05%
62,059
-10,000
-14% -$413K
2022 Q1
6 quarters
PHYT icon
170
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$2.78M 0.05%
254,990
– –
2022 Q1
6 quarters
VSAC icon
171
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.77M 0.05%
254,212
– –
2022 Q1
6 quarters
RARE icon
172
Ultragenyx Pharmaceutical
RARE
$1.53B
$2.74M 0.05%
76,915
+9,567
+14% +$379K
2022 Q4
3 quarters
BSX icon
173
Boston Scientific
BSX
$61.9B
$2.71M 0.05%
51,392
+10,000
+24% +$524K
2022 Q1
6 quarters
UDR icon
174
UDR
UDR
$11B
$2.69M 0.05%
+75,442
New +$3.01M
2023 Q3
0 quarters
ABBV icon
175
AbbVie
ABBV
$489B
$2.67M 0.05%
17,900
-23,700
-57% -$3.48M
2022 Q3
4 quarters
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.